To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

Quarterly results

rupeeShow figures in :
rupeeShow figures in :

Quarterly results

Quarter ended on June 30, 2025Data in Crores of INR
Revenue
6.96K+3.94% from last year
Operating profits
2.04K+8.57% from last year
Net income
1.29K+9.84% from last year

Financial reports

Data is unavailable

INCOME STATEMENTinfo2
Data in Crores of INR

Data is unavailable

BALANCE SHEETinfo2
Data in Crores of INR
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007
Net worth31193.4526706.4323407.7820841.6918326.5315763.0015012.2814229.1912543.6611516.2210801.4910050.359018.687638.936666.135910.574347.803755.173236.01
Fixed assets9895.149493.619100.659621.919393.779558.599546.519949.149490.249368.326829.646496.473609.973215.493094.182011.171992.491661.361388.07
Debt92.10247.02520.36824.141755.562816.434316.234098.054112.665201.921703.331247.91967.0729.17571.895.07940.24540.45123.56
docView detailed balance sheet
arrow
CASH FLOWinfo2
Data in Crores of INR
FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013FY2012FY2011FY2010FY2009FY2008FY2007
Operating5004.984133.913237.653325.903755.203068.451691.141462.762381.761740.811173.431563.311397.671712.761025.101043.03374.83367.00333.94
Investing -3691.14-2988.03-2388.51-1871.88-2387.18104.04-1668.68-854.01-1310.21-4522.63-941.15-1249.86-2062.89-965.10-908.39-562.75-580.06-674.41-484.70
Financing -1292.79-1200.43-958.29-1599.79-1239.51-2948.82-348.72-385.48-1325.683104.06164.78-265.63717.77-753.17-82.80-471.61178.92254.83238.56

Financial ratios

Profitability ratiosinfo2
ROA15.36%
ROE18.34%
ROCE23.64%
EPS65.29%
Net profit margin19.21%
Operating profit margin21.57%
Dividend per share16%
Operational ratiosinfo2
Quick ratio3.21%
Current ratio4.24%
Interest coverage111%
Assets turnover1.08%
Debt to equity
Valuation ratiosinfo2
P/E ratio23.36%
P/B ratio3.89%
Dividend yield1.03%
EV/EBITDA
Cipla Limited, established in 1935, is a global pharmaceutical company with a strong commitment to make medicines accessible and affordable to those in need. The company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). Its product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS and various other key therapeutic segments. With a rich portfolio, the company is deepening its presence in the home markets of India, as well as South Africa, North America and other key regulated and emerging markets.
personal

Grow your wealth with more research recommendations

+91